Cancer prevalence in Northern Europe: the EUROPREVAL study
Möller T.; Anderson H.; Aareleid T.; Hakulinen T.; Storm H.; Tryggvadottir L.; Corazziari I.; Mugno E.
Annals of Oncology 2003,14:946-957
Cancer prevalence in the UK: results from the EUROPREVAL study
Forman D.; Stockton D.; Møller H.; Quinn M.; Babb P.; De Angelis R.; Micheli A.
Annals of Oncology 2003,14:648-654
Cancer prevalence in central Europe :the EUROPREVAL study
Lutz J.M.; Francisci S.; Mugno E.; Usel M.; Pompe-Kirn V.; Coebergh J.W.;
Bieslka-Lasota M.; On behalf of the EUROPREVAL Working Group.
Annals of Oncology 2003,14:313-322
A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain
Verdecchia A.; Micheli A.; Colonna M.; Moreno V.; Izarzugaza M.I.; Paci E.
Annals of Oncology 2002,13:1128-1139
Cancer Prevalence in European Registry Areas
Micheli A.; Mugno E.; Krogh V.; Quinn M.J.; Coleman M.; Hakulinen T.; Gatta G.;
Berrino F.; Capocaccia R.
Annals of Oncology 2002,13:840-865
Measuring cancer prevalence in Europe: the EUROPREVAL Project
Capocaccia R.; Colonna M.; Corazzieri I.; De Angelis R.; Francisci S.; Micheli A.; Mugno E.
Annals of Oncology 2002,13:831-839
